Hazards Monitoring Bionano Research Center, KRIBB, 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, South Korea; Department of Biosystems and Bioengineering, KRIBB School of Biotechnology, Korea University of Science and Technology (UST), 217 Gajeong-ro, Yuseong-gu, Daejeon, South Korea.
Hazards Monitoring Bionano Research Center, KRIBB, 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, South Korea.
Biochim Biophys Acta Biomembr. 2018 Jun;1860(6):1318-1325. doi: 10.1016/j.bbamem.2018.02.027. Epub 2018 Mar 6.
Previously a scalable and extrusion-free method has been developed for efficient liposomal encapsulation of DNA by twice stepwise mixing of lipids in ethanol and DNA solution using T-shape mixing chamber. In this study, we prepared nanoliposomes encapsulating siRNA by simply discontinuous mixing of lipids in ethanol/ether/water mixture and acidic siRNA solution without use of special equipment. The simple mixing siRNA/liposomal particles (siRNA/SMLs) prepared using ethanol/ether/water (3:1:1) mixture showed 120.4 ± 20.2 nm particle size, 0.174 ± 0.033 polydispersity and 86.5 ± 2.76% siRNA encapsulation rate. In addition, the SMLs almost completely protected the encapsulated siRNA from RNase A digestion. Coupling of anti-human epidermal growth factor receptor (EGFR) Fab' to siRNA/SMLs enhanced EGFR-specific cell penetration of SMLs and induced siRNA dependent gene silencing. Unexpectedly, the Cy5.5-labeled Fab' showed almost no in vivo targeting to the xenografted A549 tumors in SCID-NOD mice. However, multiple injection of the unmodified siRNA/SMLs accumulated in the tumors and induced siRNA-dependent in vivo gene silencing. These results demonstrate that the siRNA/SMLs can be used as a siRNA delivery tool for gene therapy.
先前已经开发出一种可扩展且无需挤出的方法,通过在 T 型混合室中两次逐步混合乙醇中的脂质和 DNA 溶液,来高效地将 DNA 包封在脂质体中。在这项研究中,我们通过简单地将脂质在乙醇/乙醚/水混合物中和酸性 siRNA 溶液中进行不连续混合,而无需使用特殊设备来制备包封 siRNA 的纳米脂质体。使用乙醇/乙醚/水(3:1:1)混合物制备的简单混合 siRNA/脂质体颗粒(siRNA/SMLs)的粒径为 120.4±20.2nm,多分散性为 0.174±0.033,siRNA 包封率为 86.5±2.76%。此外,SMLs 几乎完全可以防止包封的 siRNA 被 RNase A 消化。将抗人表皮生长因子受体(EGFR)Fab'偶联到 siRNA/SMLs 上增强了 SMLs 的 EGFR 特异性细胞穿透能力,并诱导了 siRNA 依赖性基因沉默。出乎意料的是,Cy5.5 标记的 Fab'几乎没有对 SCID-NOD 小鼠异种移植的 A549 肿瘤进行体内靶向。然而,多次注射未修饰的 siRNA/SMLs 会在肿瘤中积累,并诱导 siRNA 依赖性体内基因沉默。这些结果表明,siRNA/SMLs 可用作基因治疗的 siRNA 递送工具。